Xiaoxia Chu
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Pathology and Forensic Medicine top 10%
- Autoimmune Bullous Skin Diseases
Papers in
- Hematology 13
- Platelet Disorders and Treatments 5
- Acute Myeloid Leukemia Research 5
- Blood groups and transfusion 2
- Multiple Myeloma Research and Treatments 2
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Ming Hou (6 shared papers)Jun Peng (4 shared papers)Li-Zhen Li (3 shared papers)Lin Wang (2 shared papers)Daoxin Ma (1 shared paper)Yuanyuan Zhu (1 shared paper)Chengshan Guo (3 shared papers)Yingxue Wang (1 shared paper)
- Journals
- Blood (4 papers)Scientific Reports (1 paper)Translational Oncology (1 paper)Hematological Oncology (1 paper)Journal of Thrombosis and Haemostasis (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoxia Chu
27 papers receiving 388 citations
Peers
Comparison fields: 5 of 50
- Hematology 280
- Pathology and Forensic Medicine 109
- Genetics 51
- Immunology and Allergy 25
- Immunology 69
Countries citing papers authored by Xiaoxia Chu
This map shows the geographic impact of Xiaoxia Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxia Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxia Chu more than expected).
Fields of papers citing papers by Xiaoxia Chu
This network shows the impact of papers produced by Xiaoxia Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxia Chu. The network helps show where Xiaoxia Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxia Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 126 | |
| 2 | 2007 | 84 | |
| 3 | 2019 | 35 | |
| 4 | 2021 | 35 | |
| 5 | 2008 | 23 | |
| 6 | 2014 | 17 | |
| 7 | 2017 | 12 | |
| 8 | 2019 | 12 | |
| 9 | 2010 | 10 | |
| 10 | 2024 | 6 | |
| 11 | 2016 | 5 | |
| 12 | Co-existence of t(9;22) and t(8;21) in primary blast phase of chronic myelogenous leukemia: clinical experience and literature review. | 2019 | 4 |
| 13 | 2021 | 3 | |
| 14 | 2020 | 3 | |
| 15 | A novel factor X gene mutation Val (GTC) 384Ala (GCC) in a Chinese family resulting in congenital factor X deficiency. | 2015 | 3 |
| 16 | 2022 | 2 | |
| 17 | [Role of dendritic cells and their Toll-like receptor 4 in the pathogenesis of idiopathic thrombocytopenic purpura]. | 2010 | 2 |
| 18 | 2015 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2018 | 1 |
About Xiaoxia Chu
Xiaoxia Chu is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Molecular Biology, having authored 30 papers that have together received 393 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Platelet Disorders and Treatments (5 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Blood groups and transfusion (2 papers), CAR-T cell therapy research (2 papers), Lung Cancer Research Studies (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (280 citations), Pathology and Forensic Medicine (109 citations), Genetics (51 citations), Immunology and Allergy (25 citations) and Immunology (69 citations). Xiaoxia Chu has collaborated with scholars based in China and United States. Frequent co-authors include Ming Hou, Jun Peng, Li-Zhen Li, Lin Wang, Daoxin Ma, Yuanyuan Zhu, Chengshan Guo, Yingxue Wang, Yan Shi and Xiaoqian Liu. Their work appears in journals such as Blood, Scientific Reports, Translational Oncology, Hematological Oncology and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.